Elena Ridloff, Director at Kymera Therapeutics, Inc. (KYMR), sold 4,500 shares at $50.00 ($225K) on 2025-06-11, disclosed to the SEC on 2025-06-11.
Scheduled sale ($225k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SION | SELL | 2025-09-03 | $462K | — | Filing → |
| SION | SELL | 2025-08-28 | $1.1M | — | Filing → |
| SION | SELL | 2025-08-21 | $1.9M | — | Filing → |